Barclays Maintains Equal-Weight on Encompass Health, Raises Price Target to $70
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Jason Goldberg maintains an Equal-Weight rating on Encompass Health (NYSE:EHC) and raises the price target from $61 to $70.
August 04, 2023 | 3:48 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays maintains an Equal-Weight rating on Encompass Health and raises the price target from $61 to $70.
The news is directly related to Encompass Health (EHC). Barclays' decision to maintain an Equal-Weight rating indicates a neutral outlook for the company. However, the increase in the price target from $61 to $70 suggests a positive short-term impact on the stock as it implies that the analyst sees potential for the stock's price to rise.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100